BazEkon - Biblioteka Główna Uniwersytetu Ekonomicznego w Krakowie

BazEkon home page

Meny główne

Autor
Niżankowski Rafał (Uniwersytet Jagielloński), Koperny Magdalena (Stacja Sanitarno-Epidemiologiczna w Krakowie), Kargul Agnieszka (Stacja Sanitarno-Epidemiologiczna w Krakowie), Seweryn Michał (Uniwersytet Jagielloński Collegium Medicum.)
Tytuł
Availability of Pneumococcal Vaccination Programmes in Europe. An Overview of Funding Mechanisms
Źródło
Journal of Health Policy and Outcomes Research, 2013, nr 1, s. 38-49, rys., tab., bibliogr. 14 poz.
Słowa kluczowe
Ochrona zdrowia, Finansowanie ochrony zdrowia, Wydatki na ochronę zdrowia
Health care protection, Health care financing, Expenditures on health care
Uwagi
summ.
Abstrakt
Increasing antibiotic resistance is a global problem. Vaccinations is one of the best solution to reduce the burden of infectious diseases. Despite universal access to antibiotics, pneumococci still are one of the major causes of morbidity and mortality in both developing and developed countries. Criteria for making the decision on financing immunisation are similar in many countries and include identifying the target groups based on epidemiological risk, the clinical efficacy and safety of a vaccine, and the economic aspects of the implementation of vaccination. To reduce the risk of diseases caused by Diplococcus pneumoniae pneumococcal conjugate vaccine (PCV) is included in national immunisation programmes in most countries. The paper describe international differences of organisations and funding mechanisms for pneumococcal vaccination. The analysis covered 34 countries in Europe. The study analyzed availability and type of vaccines used in vaccination programmes, children in the target age group to vaccination, vaccination financing, level of co-payment to vaccination for children and mechanism of purchasing vaccines. In most European countries, PCV is included in national immunisation programmes. The differences regard the availability of two types of conjugate pneumococcal vaccines (10-valent and 13-valent). The method of recommending vaccines, mechanism of purchasing and funding in different countries is varies.(original abstract)
Pełny tekst
Pokaż
Bibliografia
Pokaż
  1. Atkinson W., Wolfe Ch., Hamborsky J. Epidemiology and Prevention of Vaccine-Preventable Diseases The Pink Book. Centers for Disease Control and Prevention eds. 12th ed., second printing. Washington DC: Public Health Foundation, 2012; 233-246
  2. Summary of Product Characteristics Prevenar 13. Available from: http://www.ema.europa.eu/docs/pl_PL/document_library/EPAR_-_Product_Information/human/001104/WC500057247.pdf [Accessed: 28.03.2013]
  3. Fraser G., Hruba F., Quinton Ch., Albu C. Annual Epidemiological Report 2012. Reporting on 2010 surveillance data and 2011 epidemic intelligence data. Stockholm; ECDC 2013
  4. Akinsanya-Beysolow I., Jenkins R., Meissner C. Advisory Committee on Immunization Practices (ACIP) Recommended Immunization Schedule for Persons Aged 0 Through 18 Years - United States, 2013
  5. Pneumococcal vaccines WHO position paper-2012. Wkly Epidemiol Rec 2012; 87(14): 129-144
  6. Cylwik A., Grzesiowski P., Parda R., Proposed amendments to the national immunisation system aimed to develop access to vaccination in Poland. Infection Prevention Institute. Warsaw, November 2012.
  7. Pneumococcal vaccination (PCV) overview in European countries. EUVAC. net A surveillance community Network for vaccine preventable infectious diseases. Available from: http://www.euvac.net/graphics/euvac/vaccination/pcv.html; [Accessed: 06.04.2013]
  8. Freysson L., Wahring L. General government expenditure in 2011 - Focus on the functions 'social protection' and 'health'. Economy and Finance. Eurostat Statistics in focus 9/2013
  9. Statement of the Chief Sanitary Inspector of 29 October 2012 on Preventive Immunisation Programme in 2013, Journal of Laws 2012 item. 78
  10. Nelaj E, Bino S, Preza I, Albanian vaccination coverage 2009-2010, Institute of Public Health. Available from: http://ecdc.europa.eu/en/eurovaccine/Documents/Eurovaccine_2011_Nelaj.pdf ; [Accessed: 20.04.2013]
  11. Moreno-Perez D., Alvarez Garcia .J., Aristegui Fernández J. Immunization schedule of the Spanish Association of Pediatrics: 2012 recommendations. An Pediatr (Barc). 2012; 76(1): 43
  12. WHO Vaccine Preventable Diseases Monitoring System. Available from: http://apps.who.int/immunization_monitoring/globalsummary/; [Accessed: 16.04.2013]
  13. Rieck T. Impfquoten bei der Schuleingangsuntersuchung in Deutschland 2011. Epidemiologisches Bulletin 22 April; 16/2013
  14. Act of 29 January 2004 Public Procurement Law Dz. U. of 2004 No. 19 item. 177 as amended
Cytowane przez
Pokaż
ISSN
2299-1247
Język
eng
URI / DOI
http://dx.doi.org/10.7365/JHPOR.2013.3.3
Udostępnij na Facebooku Udostępnij na Twitterze Udostępnij na Google+ Udostępnij na Pinterest Udostępnij na LinkedIn Wyślij znajomemu